Skip to main content
. Author manuscript; available in PMC: 2022 Jun 8.
Published in final edited form as: Expert Rev Vaccines. 2014 Jan 9;13(3):333–44. doi: 10.1586/14760584.2014.878653

Figure 2. Vaccines currently in development against human respiratory syncytial virus infection.

Figure 2

Many candidate vaccines are at preclinical stage. However, there is live attenuated, particle-based, subunit and gene-based vectors being tested at Phase I or II trials. The respiratory syncytial virus vaccine snapshot is reproduced with permission from PATH and can be found at [84]. Reproduced with permission from the PATH [101].